Influenza clinical trials at UCSF
3 in progress, 2 open to new patients
-
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant
open to eligible people ages 3-17
This phase II randomized trial studies how well high dose flu vaccine works in treating children who have undergone done stem cell transplant. Higher dose flu vaccine may build a better immune response and may provide better protection against the flu than the standard vaccine.
San Francisco, California and other locations
-
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
open to eligible people ages 18 years and up
INVESTED will test the hypothesis that high dose trivalent influenza vaccine will reduce cardiopulmonary events to a greater extent than standard dose quadrivalent influenza vaccine in high-risk cardiovascular patients with a recent history of myocardial infarction or heart failure. The trial will enroll 9300 participants over one Vanguard (pilot) season and three additional influenza seasons. The primary endpoint will be a composite of all-cause mortality or cardiopulmonary hospitalization.
San Francisco, California and other locations
-
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection
Sorry, not currently recruiting here
The purpose of this study is to evaluate the clinical and virologic benefit of pimodivir in combination with Standard-of-Care (SOC) treatment compared to placebo in combination with SOC treatment.
Fresno, California and other locations
Last updated: